The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2023

Filed:

Dec. 14, 2018
Applicants:

Crispr Therapeutics Ag, Zug, CH;

Bayer Healthcare Llc, Whippany, NJ (US);

Inventors:

Andre Cohnen, Titz-Hasselsweiler, DE;

Moritz Schmidt, Cologne, DE;

Wayne Coco, Pulheim, DE;

Ashish Gupta, Leverkusen, DE;

Jan Tebbe, Leverkusen, DE;

Cindy Schulenburg, Leverkusen, DE;

Christian Pitzler, Leverkusen, DE;

Michael Biag Gamalinda, Leverkusen, DE;

Sabine Jach, Leverkusen, DE;

Florian Richter, Leverkusen, DE;

Anup Arumughan, Leverkusen, DE;

Corinna Saalwächter, Leverkusen, DE;

Assignees:

BAYER HEALTHCARE LLC, Whippany, NJ (US);

CRISPR THERAPEUTICS AG, Zug, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 9/22 (2013.01); C12N 2310/20 (2017.05); C12N 2800/80 (2013.01);
Abstract

Aspects of this invention inter alia relate to novel systems for targeting, editing or manipulating DNA in a cell, comprising one or more heterologous vector(s) encoding a SluCas9 nuclease fromor variants thereof, and one or more guide RNAs (gRNAs), or a SluCas9 nuclease or variant thereof and one or more gRNAs.


Find Patent Forward Citations

Loading…